Page 435 - ePaper
P. 435
50 Social Health Athens Science National The proposal is to create the ATHENS SCIENCE & TECHNOLOGY Yes The project is in the 0.02 0.01 A project like this is long overdue in
Infrastructur & Technology Hellenic PARK (ASTP), a concept that includes an R&D hub, an incubator and initial phase of Greece and in Athens in particular.
e Park (ASTP) Research an investment fund that will invest in the activities of the Park. The preparation. The The partners are Research Centers
Foundation primary activities of the Companies that will be hosted in the private investors of private interest plus Corporations
(NHRF) as Park will be in the area of life science applications, energy/photonic that have shown with extended R&D
coordinator, applications as well as information and communications technologies interest in the activities. All of the above
with the (ICT) applications. project are mentioned hurtles (lack of public
following expecting the and/or private financing, regulatory
potential details regarding barriers, slow project preparation)
partners: the public were obstacles to implemented a
Institute contribution and the project like this in the past but we
Pasteur reference scheme are now optimistic we will use the
Hellenique, under which ASTP “best practices” from similar project
Hellenic will operate. ASTP implemented abroad to make rapid
Federation of will run under its progress in Greece as well.
Enterprises own legal presence
(SEV), Pfizer and its own
Inc, management team.
Pharmaten,
Lavifarm,
Evaggelismos
Hospital,
University of
Athens
Medical
School ,
Advent
Technologies,
E-Nios, S&B
Corporation
51 Knowledge Private R&D HUMAB Private Τhe Hellenic Pasteur No Under planning 0.01 0 Lack of long-term finance. A
and the Project promoter – Institute has planned combination of EC grants and
digital The Hellenic the development of private funds is envisaged. A
economy Pasteur nfrastructure for the project management unit will
Institute large-scale production supervise the project’s planning
of fu|ly-human and implementation under
naturally-occurring the close supervision of
mοnοclonal antibodies the promoter.
expressing bioΙogical
activities that are
suitab|e for clinicaI
therapeutic
applications
52 Social Health BIO-SECURE Private Τhe Hellenic Pasteur No HPI is currently 0.01 0.007 Lack of long-term finance. A
Infrastructur Project promoter – Institute is pursuing organizing combination of EC grants and
e The Hellenic the development of a a Bioinformatics private funds is envisaged.
Pasteur Next Generation core facility with
Institute (HPI) Sequencing (NGS) emphasis in the
Technology and analysis of NGS
Bioinformatics Unit for data.
improved diagnosis,
surveillance and
control of infectious
diseases
Infrastructur & Technology Hellenic PARK (ASTP), a concept that includes an R&D hub, an incubator and initial phase of Greece and in Athens in particular.
e Park (ASTP) Research an investment fund that will invest in the activities of the Park. The preparation. The The partners are Research Centers
Foundation primary activities of the Companies that will be hosted in the private investors of private interest plus Corporations
(NHRF) as Park will be in the area of life science applications, energy/photonic that have shown with extended R&D
coordinator, applications as well as information and communications technologies interest in the activities. All of the above
with the (ICT) applications. project are mentioned hurtles (lack of public
following expecting the and/or private financing, regulatory
potential details regarding barriers, slow project preparation)
partners: the public were obstacles to implemented a
Institute contribution and the project like this in the past but we
Pasteur reference scheme are now optimistic we will use the
Hellenique, under which ASTP “best practices” from similar project
Hellenic will operate. ASTP implemented abroad to make rapid
Federation of will run under its progress in Greece as well.
Enterprises own legal presence
(SEV), Pfizer and its own
Inc, management team.
Pharmaten,
Lavifarm,
Evaggelismos
Hospital,
University of
Athens
Medical
School ,
Advent
Technologies,
E-Nios, S&B
Corporation
51 Knowledge Private R&D HUMAB Private Τhe Hellenic Pasteur No Under planning 0.01 0 Lack of long-term finance. A
and the Project promoter – Institute has planned combination of EC grants and
digital The Hellenic the development of private funds is envisaged. A
economy Pasteur nfrastructure for the project management unit will
Institute large-scale production supervise the project’s planning
of fu|ly-human and implementation under
naturally-occurring the close supervision of
mοnοclonal antibodies the promoter.
expressing bioΙogical
activities that are
suitab|e for clinicaI
therapeutic
applications
52 Social Health BIO-SECURE Private Τhe Hellenic Pasteur No HPI is currently 0.01 0.007 Lack of long-term finance. A
Infrastructur Project promoter – Institute is pursuing organizing combination of EC grants and
e The Hellenic the development of a a Bioinformatics private funds is envisaged.
Pasteur Next Generation core facility with
Institute (HPI) Sequencing (NGS) emphasis in the
Technology and analysis of NGS
Bioinformatics Unit for data.
improved diagnosis,
surveillance and
control of infectious
diseases
